Voxel S.A. (WSE:VOX)
Poland · Delayed Price · Currency is PLN 128.60
-1.00 (-0.77%)
Aug 14, 2026, 5:02 PM CET
Voxel Financials Overview
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 583.14 | 583.79 | 507.77 | 424.18 | 360.64 | 442.66 |
Revenue Growth | 4.70% | 14.97% | 19.71% | 17.62% | -18.53% | 35.10% |
Gross Profit Gross Profit Growth | 176.7 | 167.95 | 154.16 | 135.12 | 104.1 | 126.33 |
Operating Income Operating Income Growth | 142.77 | 134.35 | 128.88 | 112.15 | 83.34 | 103.66 |
Net Income Net Income Growth | 106.17 | 98.53 | 96.45 | 74.2 | 44.43 | 70.55 |
Earnings Per Share EPS Growth | 10.11 | 9.38 | 9.18 | 7.06 | 4.23 | 6.72 |
EPS Growth | 4.65% | 2.18% | 29.97% | 67.06% | -37.06% | 107.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Diagnostics - Medical Services and Sales of Radiopharmaceuticals Diagnostics - Medical Services and Sales of Radiopharmaceuticals Growth | 451.79 | 437.63 | 386.77 | 331.98 | 252.78 | 196.21 |
Therapy - Neuroradiosurgery Therapy - Neuroradiosurgery Growth | 15.7 | 15.25 | 13.83 | 11.92 | 10.06 | 9.1 |
IT & Infrastructure - IT Products and Laboratory Equipment IT & Infrastructure - IT Products and Laboratory Equipment Growth | 142.54 | 163.94 | 128.39 | 101.55 | 137.97 | 170.91 |
Exclusions/Unassigned Exclusions/Unassigned Growth | -26.9 | -33.03 | -21.22 | -21.27 | -40.17 | -84.33 |
Total Total Growth | 583.14 | 583.79 | 507.77 | 424.18 | 360.64 | 442.66 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 16.95 | 13.02 | 52.91 | 65.75 | 34.61 | 54.76 |
Total Debt Total Debt Growth | 196.37 | 185.65 | 126.94 | 127.12 | 138.48 | 166.86 |
Net Cash (Debt) Net Cash Growth | -179.42 | -172.62 | -74.03 | -61.37 | -103.87 | -112.1 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -17.09 | -16.44 | -7.05 | -5.84 | -9.89 | -10.67 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 137.87 | 116.69 | 122.34 | 129.01 | 96.2 | 106.34 |
Capital Expenditures CapEx Growth | -94.14 | -75.82 | -70.62 | -44.26 | -31.01 | -31.67 |
Free Cash Flow Free Cash Flow Growth | 43.73 | 40.87 | 51.72 | 84.76 | 65.19 | 74.67 |
Free Cash Flow Growth | -0.09% | -20.98% | -38.98% | 30.02% | -12.70% | 153.41% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 30.30% | 28.77% | 30.36% | 31.85% | 28.86% | 28.54% |
Operating Margin | 24.48% | 23.01% | 25.38% | 26.44% | 23.11% | 23.42% |
Pretax Margin | 23.02% | 21.28% | 23.55% | 24.10% | 19.18% | 20.22% |
Profit Margin | 18.21% | 16.88% | 19.00% | 17.49% | 12.32% | 15.94% |
FCF Margin | 7.50% | 7.00% | 10.18% | 19.98% | 18.08% | 16.87% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 4.780 | - | 4.780 | 2.780 | 2.170 | 3.000 |
Dividend Per Share Growth | -47.70% | - | 71.94% | 28.11% | -27.67% | 50.00% |
Dividend Yield | 3.72% | - | 3.90% | 3.73% | 5.41% | 7.81% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 16, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 12.72 | 12.77 | 13.72 | 11.13 | 10.40 | 6.77 |
Forward PE | 13.88 | 10.87 | 13.73 | 14.80 | 11.95 | 13.06 |
P/FCF Ratio | 30.88 | 30.79 | 25.59 | 9.74 | 7.09 | 6.40 |
PS Ratio | 2.32 | 2.15 | 2.61 | 1.95 | 1.28 | 1.08 |